Performance of Nonlinear Mixed Effects Models in the Presence of Informative Dropout

被引:15
作者
Bjornsson, Marcus A. [1 ,2 ]
Friberg, Lena E. [2 ]
Simonsson, Ulrika S. H. [2 ]
机构
[1] AstraZeneca R&D, S-15185 Sodertalje, Sweden
[2] Uppsala Univ, Dept Pharmaceut Biosci, Uppsala, Sweden
关键词
bias; informative dropout; nonlinear mixed effects; NONMEM; MISSING DATA; SIMULATION; NONMEM;
D O I
10.1208/s12248-014-9700-x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Informative dropout can lead to bias in statistical analyses if not handled appropriately. The objective of this simulation study was to investigate the performance of nonlinear mixed effects models with regard to bias and precision, with and without handling informative dropout. An efficacy variable and dropout depending on that efficacy variable were simulated and model parameters were reestimated, with or without including a dropout model. The Laplace and FOCE-I estimation methods in NONMEM 7, and the stochastic simulations and estimations (SSE) functionality in PsN, were used in the analysis. For the base scenario, bias was low, less than 5% for all fixed effects parameters, when a dropout model was used in the estimations. When a dropout model was not included, bias increased up to 8% for the Laplace method and up to 21% if the FOCE-I estimation method was applied. The bias increased with decreasing number of observations per subject, increasing placebo effect and increasing dropout rate, but was relatively unaffected by the number of subjects in the study. This study illustrates that ignoring informative dropout can lead to biased parameters in nonlinear mixed effects modeling, but even in cases with few observations or high dropout rate, the bias is relatively low and only translates into small effects on predictions of the underlying effect variable. A dropout model is, however, crucial in the presence of informative dropout in order to make realistic simulations of trial outcomes.
引用
收藏
页码:245 / 255
页数:11
相关论文
共 14 条
[1]  
Beal S. L., 1989, NONMEM USERS GUIDES
[2]   Modelling of pain intensity and informative dropout in a dental pain model after naproxcinod, naproxen and placebo administration [J].
Bjornsson, Marcus A. ;
Simonsson, Ulrika S. H. .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 71 (06) :899-906
[3]   Modeling and Simulation of the Time Course of Asenapine Exposure Response and Dropout Patterns in Acute Schizophrenia [J].
Friberg, L. E. ;
de Greef, R. ;
Kerbusch, T. ;
Karlsson, M. O. .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2009, 86 (01) :84-91
[4]   Missing Data in Model-Based Pharmacometric Applications: Points to Consider [J].
Gastonguay, Marc R. ;
French, Jonathan L. ;
Heitjan, Daniel F. ;
Rogers, James A. ;
Ahn, Jae Eun ;
Ravva, Patanjali .
JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 50 (09) :63S-74S
[5]   Modelling placebo response in depression trials using a longitudinal model with informative dropout [J].
Gomeni, Roberto ;
Lavergne, Agnes ;
Merlo-Pich, Emilio .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2009, 36 (01) :4-10
[6]   STATISTICAL HANDLING OF DROP-OUTS IN LONGITUDINAL CLINICAL-TRIALS [J].
HEYTING, A ;
TOLBOOM, JTBM ;
ESSERS, JGA .
STATISTICS IN MEDICINE, 1992, 11 (16) :2043-2061
[7]   Informative dropout modeling of longitudinal ordered categorical data and model validation: application to exposure-response modeling of physician's global assessment score for ustekinumab in patients with psoriasis [J].
Hu, Chuanpu ;
Szapary, Philippe O. ;
Yeilding, Newman ;
Zhou, Honghui .
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2011, 38 (02) :237-260
[8]   A joint model for nonlinear longitudinal data with informative dropout [J].
Hu, CP ;
Sale, ME .
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2003, 30 (01) :83-103
[9]  
Jonsson EN, 1999, COMPUT METH PROG BIO, V58, P51, DOI 10.1016/S0169-2607(98)00067-4
[10]   MISSING DATA IN LONGITUDINAL-STUDIES [J].
LAIRD, NM .
STATISTICS IN MEDICINE, 1988, 7 (1-2) :305-315